SIGNAL works closely with the most senior Chinese and Israeli leaders to enhance strategic, diplomatic, cultural and economic relationships through long-term scholarly alliances between both countries. More
SIGNAL’s 2nd Annual Conference on Israel’s China Policy

On Dec 26, 2017, SIGNAL, in cooperation with the Institute for Policy and Strategy at IDC Herzliya and the Israel Council on Foreign Relations, held its 2nd annual conference on Israel’s China Policy. This year’s conference, “China on the World Stage – Strategic Implications for Israel,” provided a forum for discussing China’s “New Era” and the Middle Kingdom’s engagement in the turbulent Middle East.

The conference was divided into two sections, a closed, morning session that simulated conflict between the US and North Korea, and afternoon round-table styled discussions open to the general public, conducted for an overflow crowd. The 4-hour, morning simulation included over a dozen scholars and experts from Israeli and Chinese think tanks, former diplomats and retired military personnel who represented the USA, Russia, Iran, North Korea, Israel, Japan and South Korea. North Korea’s representation included former Mossad director Efraim Halevy and former Chinese representative to the 6 Party Talks, Mr. Yang Xiyu.

SIGNAL Note 31

Israel’s Innovative Digital Health Sector, and its Applications to the BRI


Introduction

As China develops its digital healthcare system and promotes impactful policy coordination across the Belt and Road Initiative (BRI), turning towards Israeli innovation could enable win-win cooperation. On the domestic front, the digital health sector will help advance objectives stated in China’s 13th Five-Year Plan. This includes the distribution of health resources and the promotion of healthcare quality at the local level. On the international front, advancing the digital health sector can solidify China’s geopolitical role as a global leader in healthcare reform. Forming a model healthcare template for nations participating in the BRI is important given that the initiative promotes cooperation in scientific and cultural exchange to improve the quality of life in health and medicine of all citizens in BRI nations.

With Israel’s advancements in medical technology and digital health, the Sino-Israel partnership will apply the uniqueness of Israel’s innovation market, and will alleviate inefficiencies in China’s healthcare system. Thus, potential business-to-business (B2B) cooperation in this area will be a compelling means to promote progress in Sino-Israel relations.

Academic Collaborations